BB:IBAB Ion Beam Applications SA

Ion Beam Applications SA, a medical technology company, focuses on providing solutions for the diagnosis and treatment of cancer in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. It offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or single photon emission computed tomography radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides measurement and quality assurance instruments for radiotherapy and medical imaging to enable healthcare professionals to verify that equipment administers the planned dose to the targeted area. Ion Beam Applications, S.A. has a strategic alliance with RaySearch Laboratories AB for the advancement of adaptive proton therapy. The company was founded in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

14.52 EUR
As of 01/14/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  Belgium
Country of incorporation:  Belgium
IPO date:  01/03/2000
Stock exchange:    Nyse Euronext - Euronext
Exchange country:   Belgium
Market cap:   426,420,480 EUR
Current dividend yield:   1.37%
Sedol:      5705496

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy